PDX models Market Forecast to 2028 - COVID-19 Impact and Global Analysis By : Type (Mice Models, Rat Models); Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Hematological Tumor Models, Other Tumor Models); Application (Preclinical Drug Development, Basic Cancer Research, Biomarker Analysis); End Users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutions), Impact of covid-19 pandemic.
Report Code: TIPRE00014250 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Patient derived xenografts (PDX) are oncology models in which the tissue or cells from a tumor of cancer patients are implanted into an immunodeficient or humanized mouse. PDX models have been used to develop an environment that promotes the natural growth of cancer, its monitoring, and accordingly evaluate the course of treatment for the original cancer patient. Various cancer drugs and therapies can be tested on xenografts to examine their efficacy before administering it to the patient's body. Patient-derived xenografts can be used to help with treatment planning and to understand the best treatment that can be given to the patient. They are also being used to develop new cancer drugs.
MARKET DYNAMICS
The PDX models market is driving due to the increasing demand for personalized medicine, increasing emphasis on cancer research from the government as well as private organizations, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent regulatory guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.
MARKET SCOPE
The PDX Models market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PDX Models market with detailed market segmentation by products and applications. The PDX Models market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PDX Models market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The PDX Models market is segmented on the basis of type, tumor type, applications and end user. Based on type, the market is segmented as mice models, rat models. On the basis of tumor type market can be segmented as gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, other tumor models. On the basis of applications market can be segmented as preclinical drug development, basic cancer research, biomarker analysis. On the basis of end users market can be segmented as pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PDX Models market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PDX Models market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting PDX Models market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PDX Models market in these regions.
The report covers key developments in the PDX Models market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PDX Models market are anticipated to have lucrative growth opportunities in the future with the rising demand for PDX Models in the global market. Below mentioned is the list of few companies engaged in the PDX Models market.
The report also includes the profiles of key players in PDX Models market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Patient derived xenografts (PDX) are oncology models in which the tissue or cells from a tumor of cancer patients are implanted into an immunodeficient or humanized mouse. PDX models have been used to develop an environment that promotes the natural growth of cancer, its monitoring, and accordingly evaluate the course of treatment for the original cancer patient. Various cancer drugs and therapies can be tested on xenografts to examine their efficacy before administering it to the patient's body. Patient-derived xenografts can be used to help with treatment planning and to understand the best treatment that can be given to the patient. They are also being used to develop new cancer drugs.
MARKET DYNAMICS
The PDX models market is driving due to the increasing demand for personalized medicine, increasing emphasis on cancer research from the government as well as private organizations, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent regulatory guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.
MARKET SCOPE
The PDX Models market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PDX Models market with detailed market segmentation by products and applications. The PDX Models market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PDX Models market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The PDX Models market is segmented on the basis of type, tumor type, applications and end user. Based on type, the market is segmented as mice models, rat models. On the basis of tumor type market can be segmented as gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, other tumor models. On the basis of applications market can be segmented as preclinical drug development, basic cancer research, biomarker analysis. On the basis of end users market can be segmented as pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PDX Models market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PDX Models market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting PDX Models market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PDX Models market in these regions.
The report covers key developments in the PDX Models market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PDX Models market are anticipated to have lucrative growth opportunities in the future with the rising demand for PDX Models in the global market. Below mentioned is the list of few companies engaged in the PDX Models market.
The report also includes the profiles of key players in PDX Models market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Crown Bioscience Inc.
- WuXi AppTec
- Champions Oncology, Inc..
- The Jackson Laboratory
- ONCODESIGN
- Charles River Laboratories International, Inc.
- EPO Berlin-Buch GmBH
- Shanghai LIDE Biotech Co., Ltd.
- Xentech
- Horizon Discovery Group PLC
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Crown Bioscience Inc.
2. WuXi AppTec
3. Champions Oncology, Inc..
4. The Jackson Laboratory
5. ONCODESIGN
6. Charles River Laboratories International, Inc.
7. EPO Berlin-Buch GmBH
8. Shanghai LIDE Biotech Co., Ltd.
9. Xentech
10. Horizon Discovery Group PLC
1. Crown Bioscience Inc.
2. WuXi AppTec
3. Champions Oncology, Inc..
4. The Jackson Laboratory
5. ONCODESIGN
6. Charles River Laboratories International, Inc.
7. EPO Berlin-Buch GmBH
8. Shanghai LIDE Biotech Co., Ltd.
9. Xentech
10. Horizon Discovery Group PLC
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount